Hide metadata

dc.date.accessioned2021-01-20T20:02:18Z
dc.date.available2021-01-20T20:02:18Z
dc.date.created2021-01-13T12:40:15Z
dc.date.issued2020
dc.identifier.citationFjermestad, Krister Kanavin, Øivind J. Hoxmark, Lise Beate Nyhus, Livø . Health service experiences among adults with hereditary spastic paraparesis or neurofibromatosis type 1. Molecular Genetics & Genomic Medicine. 2020, 8, e1399
dc.identifier.urihttp://hdl.handle.net/10852/82419
dc.description.abstractBackground Persons with rare disorders may experience poorer health services due to limited knowledge about rare disorders among health professionals. Knowledge about how persons with rare disorders perceive health services can help inform service providers to enhance their practices. Methods We conducted a self‐report survey among adults with the rare disorders hereditary spastic paraparesis (HSP; n = 108; mean age 57.7 years; 54.2% females) and neurofibromatosis type 1 (NF1, n = 142; mean age = 50.3 years; 62.0% females). Their responses concerning perceived health experiences were compared to healthy controls from the population study HUNT‐3 (n = 7,312). Results Both rare disorder groups reported lower satisfaction, trust, and participation in meetings with their general practitioner and specialist health services. More reported health problems were overall associated with poorer health service experiences. Conclusion There is a need to identify predictors of health service experiences at the patient and health service provider levels with the aim to tighten the gap between the health experiences of patients with and without rare disorders.
dc.languageEN
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleHealth service experiences among adults with hereditary spastic paraparesis or neurofibromatosis type 1
dc.typeJournal article
dc.creator.authorFjermestad, Krister
dc.creator.authorKanavin, Øivind J.
dc.creator.authorHoxmark, Lise Beate
dc.creator.authorNyhus, Livø
cristin.unitcode185,17,5,0
cristin.unitnamePsykologisk institutt
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin1870585
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Molecular Genetics & Genomic Medicine&rft.volume=8&rft.spage=e1399&rft.date=2020
dc.identifier.jtitleMolecular Genetics & Genomic Medicine
dc.identifier.volume8
dc.identifier.issue10
dc.identifier.startpagee1399
dc.identifier.doihttps://doi.org/10.1002/mgg3.1399
dc.identifier.urnURN:NBN:no-85311
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn2324-9269
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/82419/2/mgg3.1399.pdf
dc.type.versionPublishedVersion


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International